Effect of Antiarrhythmic Drug Therapy on the Incidence of Shocks in Patients who Receive an Implantable Cardioverter Defibrillator after a Single Episode of Sustained Ventricular Tachycardia/Fibrillation

Seventy-four patients (16 women, 58 men, age 58 ± 21 years, mean ± standard deviation) who received an implantable Cardioverter de/ibrillator (ICD) after experiencing a single episode of ventricular tachycardia or ventricular fibrillation were followed to determine if antiarrhythmic drug therapy affects the incidence of ICD discharges. Thirty-three patients (group A) were treated with an antiarrhythmic drug that was either untested or previously demonstrated during electropharmacological testing to be ineffective in suppressing the induction of ventricular tachycardia. Forty-one patients (group B) were not treated with an antiarrhythmic drug. There were no significant differences between the two groups in regards to age, sex, incidence of coronary artery disease, left ventricular function or the type of ICD pulse generator used. During a mean follow-up of 14 months for the entire cohort, 15 patients (46%) in group A and 18 patients (44%) in group B experienced at least one ICD shock. The time to the first appropriate shock (5 ± 5 months in both groups) and the frequency of ICD shocks (0.3 ± 0.2/month in group A vs 0.4 ± 0.5/month in group B) were similar in both groups. The incidence of syncope at the time of ICD discharge was higher in group A than group B patients (31% vs 5%, P < 0.05). In conclusion, antiarrhythmic drugs that are untested or have failed electropharmacological testing do not appear to reduce the probability of ICD discharge over a short-term (mean 14 months) follow-up in patients who have had only one clinical episode of VT/VF and may increase the risk of syncope during ICD discharge. Studies with a larger sample size and longer follow-up period will be needed to confirm these findings.     

Dental Practitioners and Eating Disorders

To better understand how dental practitioners identify, counsel, and refer patients with eating disorders. A questionnaire was mailed to 625 dental practitioners, 54 (19%) of the dentists and 69 (20%) of the dental hygienists responded. Most dental practitioners were aware of eating disorder patients in their practices and most discussed their findings with their patients or parents. However, one of the suggestions most commonly given to patients, to brush immediately after vomiting, may be counter therapeutic, and a few offered referral for more health services. Collaboration between dental practitioners and mental health practitioners who work with eating disorder patients should be improved.     

The conflict between least harm and no-use tobacco policy for youth: ethical and policy implications

This paper examines policy and ethical implementation issues associated with local drug policies that are aimed at producing a "least harm" approach toward youth, with particular application to tobacco policy as an example of a legal, but addictive drug. Research is reviewed which shows the inconsistencies between federally mandated enforcement of zero tobacco use, the Synar Amendment and local community and school policies which appear to relax enforcement of no-use policies for the purpose of retaining youth in school. The inconsistencies are described from the perspective of a "least harm" approach, in that tobacco use may be considered less harmful than absence from school, or use of other substances. The conflict between law and intent to reduce harm is examined with implications for long-term enforcement of federal policy, and for effectiveness of tobacco and other drug abuse prevention programs and other drug policies. Several strategies for reducing the conflict are recommended. These include provision of support-orientated smoking cessation programs for youth on school campuses and in community organizations, and promoting consistent no-use norms across all drugs and across multiple channels that affect youth-mass media, school, point-of-purchase settings and public settings and events.     

Cartilaginous development of the human craniovertebral junction as visualised by a new three-dimensional computer reconstruction technique

Serial transverse histological sections of the human craniovertebral junction (CVJ) of 4 normal human embryos (aged 45 to 58 d) and of a fetus (77 d) were used to create 3-dimensional computer models of the CVJ. The main components modelled included the chondrified basioccipital, atlas and axis, notochord, the vertebrobasilar complex and the spinal cord. Chondrification of the component parts of CVJ had already begun at 45 d (Stage 18). The odontoid process appeared to develop from a short eminence of the axis forming a third occipital condyle with the caudal end of the basioccipital. The cartilaginous anterior arch of C1 appeared at 50–53 d (Stages 20–21). Neural arches of C1 and C2 showed gradual closure, but there was still a wide posterior spina bifida in the oldest reconstructed specimen (77 d fetus). The position of the notochord was constant throughout. The normal course of the vertebral arteries was already established and the chondrified vertebral foramina showed progressive closure. The findings confirm that the odontoid process is not derived solely from the centrum of C1 and that there is a 'natural basilar invagination' of C2 during normal embryonic development. On the basis of the observed shape and developmental pattern of structures of the cartilaginous human CVJ, we suggest that certain pathologies are likely to originate during the chondrification phase of development.     

Auditory neuropathy: unexpectedly common in a screened newborn population

Auditory neuropathy, or dyssynchrony, is defined by an abnormal or absent auditory brainstem response but intact otoacoustic emissions or cochlear microphonics. It is associated with impaired hearing on behavioural pure-tone audiometry, absent acoustic reflexes, and poor speech perception, particularly in noisy environments. These results suggest a disorder of inner hair-cell and or eighth-nerve function. We describe a case-note survey of patients with and without auditory neuropathy, using data from the local newborn hearing screening programme collected prospectively from 2002 to 2007. During this period, 45 050 infants were screened with otoacoustic emissions, 30 patients were diagnosed with suspected severe to profound hearing loss (16 males, 14 females), and 12 of those 30 had auditory neuropathy (six males, six females). Mean gestational age was 33 weeks 1 day in the auditory neuropathy group and 35 weeks in the non-auditory neuropathy group. The most significant risk factors for auditory neuropathy were hyperbilirubinaemia ( p =0.018), sepsis ( p =0.024), and gentamicin exposure ( p =0.024). Children with auditory neuropathy comprise a subgroup of patients with hearing impairment involving different pathologies most commonly associated with the risk factors related to admission to neonatal intensive care units. Improvement is possible with maturity, at least in a minority.     

Comparison of Fixed Burst Versus Decremental Burst Pacing for Termination of Ventricular Tachycardia

The objective of this study was to compare prospectively the efficacy of fixed burst pacing with that of decremental hurst pacing in terminating VT. Forty-four patients with inducible sustained monomorphic VT were studied. The efficacy of fixed burst and decremental burst pacing in terminating 57 distinct types of VT were compared during 50 eiectrophysiology tests fmean VT cycle length = 334 ± 84 msec. Termination of each type of VT was attempted with fixed burst and decremental burst pacing, Both pacing algorithms were delivered in an adaptive fashion with an increasing number of stimuli with each successive attempt at VT termination. Seventy percent of VT episodes were successfully terminated with fixed burst pacing, The mean number of stimuli required for VT termination was 5 ± 2. Seventy-two percent of VT episodes were successfully terminated with decremental burst pacing. The mean number of stimuJi required for VT termination ivas 5 ± 2. For fixed burst and decremental burst pacing, the efficacy of VT termination was greater for VTs with a cycle length > 300 msec than for faster VTs (P < 0.05). The efficacy of VT termination and the incidence of VT acceleration were no different for the two pacing algorithms (P > 0.1). The results of this study demonstrate that fixed burst and decrementai burst pacing are equally effective in terminating VT and that a single adaptive pacing algorithm is effective in terminating nearly three fourths of VTs.     

MANAGEMENT OF ECTOPIC URETEROCELE ASSOCIATED WITH RENAL DUPLICATION: A COMPARISON OF PARTIAL NEPHRECTOMY AND ENDOSCOPIC DECOMPRESSION

PURPOSE: We compared the efficacy of primary endoscopic decompression versus partial nephrectomy for treating ectopic duplex ureteroceles. MATERIALS AND METHODS: We retrospectively reviewed the records of patients with renal duplication and upper pole ectopic ureterocele. Patients were classified according to the initial radiological evaluation. The operation performed was arbitrarily chosen by the surgeon. RESULTS: A total of 54 patients had unilateral upper or bilateral upper pole ureterocele with no associated vesicoureteral reflux. Partial nephrectomy was performed in 26 patients, of whom 4 (15%) required additional surgery for new onset ipsilateral lower pole reflux. Endoscopic decompression was performed in 28 patients, of whom 18 (64%) required additional treatment due to reflux into the ipsilateral lower pole ureter and ureterocele in 9, reflux into the ureterocele only in 4, ipsilateral lower pole reflux only in 3 and persistent ureterocele obstruction in 2 (p<0.01). An ectopic ureterocele with vesicoureteral reflux into 1 or more moieties was identified in 111 patients, including 56 of 67 (84%) treated with partial nephrectomy and 37 of 44 (84%) treated with endoscopy who have persistent reflux or required further surgery for reflux resolution. CONCLUSIONS: In patients with an ectopic ureterocele and no vesicoureteral reflux partial nephrectomy should be considered the treatment of choice. However, when the initial cystogram reveals vesicoureteral reflux, partial nephrectomy and endoscopic ureterocele decompression have identical definitive cure rates of only 16%. The majority of the latter patients require continued observation and/or additional surgery for managing persistent reflux.     

The additional cost of obesity to the health service and the potential for resource savings from effective interventions

Background: Obesity affects 15% of men and 16.5% of women inthe UK (1995). UK prevalence of obesity has doubled in 10 yearsand continues to rise: it is projected to reach 18 and 24% respectivelyby 2000. Obesity is a complex condition influenced by both geneticand environmental factors and is associated with reduced longevityand increased risk of serious co-morbidities including diabetes,coronary heart disease, stroke and hypertension. Methods: Datafrom a large population survey in north-west England allowedestimation of the additional direct costs to the NHS of majorco-morbidities associated with obesity. The change in costsexpected from a lower prevalence of obesity were projected.Results: Initial estimates suggest annual reductions in healthcare spending in England of up to £131 million per annum(1996 prices) may be possible with effective Interventions forbeing overweight and obesity. This is equivalent to 11% (males)or 13% (females) of spending on the main co-morbidities andapproximately 1% of overall expenditure. Conclusions: The numberof grossly obese patients in the UK remains very small and theburden they place on the health service is not very serious.Most of the additional cost is for those moderately overweight(WHO grade 1) and research should concentrate on evaluatinginterventions that reduce the numbers in this group. Obesityoften develops at an early age, but the more expensive co-morbiditiesappear 10–20 years later. Thus, interventions targetedat younger age groups are more likely to provide significantcost savings, but must be evaluated over a lifetime to includethe full impact of chronic co-morbidities.